Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial

Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, Najib M. Rahman, Duncan B. Richards, Gail Hayward, Jienchi Dorward, David M. Lowe, Joseph F. Standing, Judith Breuer, Saye Khoo, Stavros Petrou, Kerenza Hood, Haroon Ahmed, Andrew Carson-Stevens, Jonathan S. Nguyen-Van-Tam, Mahendra G. Patel, Benjamin R. Saville, Nick Francis, Nicholas P.B. ThomasPhilip Evans, Melissa Dobson, May Ee Png, Mark Lown, Oliver van Hecke, Bhautesh D. Jani, Nigel D. Hart, Daniel Butler, Lucy Cureton, Meena Patil, Monique Andersson, Maria Coates, Clare Bateman, Jennifer C. Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Ly Mee Yu, F. D. Richard Hobbs, Paul Little, Christopher C. Butler*, PANORAMIC Trial Collaborative Group, Devesh Dhasmana

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science